Skip to main content
Top
Published in: Journal of Immigrant and Minority Health 1/2015

01-02-2015 | Original Paper

Analysis of Latent Tuberculosis Infection Treatment Adherence Among Refugees and Other Patient Groups Referred to the Baltimore City Health Department TB Clinic, February 2009–March 2011

Authors: Jennifer B. Nuzzo, Jonathan E. Golub, Patrick Chaulk, Maunank Shah

Published in: Journal of Immigrant and Minority Health | Issue 1/2015

Login to get access

Abstract

We sought to determine the proportion of refugee patients at the Baltimore City Health Department Tuberculosis program (BCHD-TB) successfully completing latent tuberculosis infection (LTBI) treatment, as compared to other referral groups, and to identify factors associated with treatment completion. We completed a retrospective cohort analysis of individuals referred to BCHD-TB program for LTBI care between February 1, 2009 and March 31, 2011. Among 841 patients evaluated by BCHD-TB and diagnosed with LTBI, 81 % of refugees, 50 % of non-refugee foreign-born, and 35 % of US-born patients completed LTBI treatment. In multivariate analysis, refugees had greater odds of LTBI treatment completion (Adjusted Odds Ratio 7.2; 95 % CI 4.2–12.4, p < 0.001) compared to US-born individuals adjusting for age, gender, and treatment regimen. Overall, LTBI treatment completion remains suboptimal. At BCHD-TB, LTBI treatment completion was significantly higher among refugees than other referral groups. Additional efforts are needed to optimize LTBI care, and future efforts may need to be tailored for different risk groups.
Literature
1.
go back to reference Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000;49:1–51. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000;49:1–51.
2.
go back to reference Centers for Disease C, Prevention. Trends in tuberculosis—United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:201–5. Centers for Disease C, Prevention. Trends in tuberculosis—United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:201–5.
3.
go back to reference LoBue PA, Enarson DA, Thoen TC. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. Int J Tuberc Lung Dis. 2010;14:1226–32.PubMed LoBue PA, Enarson DA, Thoen TC. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. Int J Tuberc Lung Dis. 2010;14:1226–32.PubMed
4.
go back to reference Geng E, Kreiswirth B, Driver C, Li J, Burzynski J, DellaLatta P, et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med. 2002;346:1453–8.PubMedCrossRef Geng E, Kreiswirth B, Driver C, Li J, Burzynski J, DellaLatta P, et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med. 2002;346:1453–8.PubMedCrossRef
5.
go back to reference Horsburgh CR Jr, Rubin EJ. Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med. 2011;364:1441–8.PubMedCrossRef Horsburgh CR Jr, Rubin EJ. Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med. 2011;364:1441–8.PubMedCrossRef
6.
go back to reference CDC. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers. In; 2010. CDC. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers. In; 2010.
7.
go back to reference Cronin W. TB in Maryland: 2012 Epidemiologic Review. In: Talk presented at: Stop TB in my lifetime: meeting the challenge in Maryland meeting;. Clarksville, MD. Cronin W. TB in Maryland: 2012 Epidemiologic Review. In: Talk presented at: Stop TB in my lifetime: meeting the challenge in Maryland meeting;. Clarksville, MD.
8.
go back to reference Hirsch-Moverman Y, Daftary A, Franks J, Colson PW. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis. 2008;12:1235–54.PubMed Hirsch-Moverman Y, Daftary A, Franks J, Colson PW. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis. 2008;12:1235–54.PubMed
9.
go back to reference Goswami ND, Gadkowski LB, Piedrahita C, Bissette D, Ahearn MA, Blain ML, et al. Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study. BMC Public Health. 2012;12:468.PubMedCentralPubMedCrossRef Goswami ND, Gadkowski LB, Piedrahita C, Bissette D, Ahearn MA, Blain ML, et al. Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study. BMC Public Health. 2012;12:468.PubMedCentralPubMedCrossRef
10.
go back to reference Hirsch-Moverman Y, Bethel J, Colson PW, Franks J, El-Sadr W. Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience. Int J Tuberc Lung Dis. 2010;14:1104–11.PubMed Hirsch-Moverman Y, Bethel J, Colson PW, Franks J, El-Sadr W. Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience. Int J Tuberc Lung Dis. 2010;14:1104–11.PubMed
11.
go back to reference Zuniga JA. Medication adherence in Hispanics to latent tuberculosis treatment: a literature review. J Immigr Minor Health. 2012;14:23–9.PubMedCrossRef Zuniga JA. Medication adherence in Hispanics to latent tuberculosis treatment: a literature review. J Immigr Minor Health. 2012;14:23–9.PubMedCrossRef
12.
go back to reference Li J, Munsiff SS, Tarantino T, Dorsinville M. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis. 2010;14:e292–7.PubMedCrossRef Li J, Munsiff SS, Tarantino T, Dorsinville M. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis. 2010;14:e292–7.PubMedCrossRef
13.
go back to reference Levesque JF, Dongier P, Brassard P, Allard R. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada. Int J Tuberc Lung Dis. 2004;8:711–7.PubMed Levesque JF, Dongier P, Brassard P, Allard R. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada. Int J Tuberc Lung Dis. 2004;8:711–7.PubMed
14.
go back to reference Trauer JM, Krause VL. Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory. Med J Aust. 2011;194:579–82.PubMed Trauer JM, Krause VL. Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory. Med J Aust. 2011;194:579–82.PubMed
15.
go back to reference Centers for Disease C, Prevention. Trends in tuberculosis—United States. MMWR Morb Mortal Wkly Rep. 2011;2012(61):181–5. Centers for Disease C, Prevention. Trends in tuberculosis—United States. MMWR Morb Mortal Wkly Rep. 2011;2012(61):181–5.
16.
go back to reference Trajman A, Long R, Zylberberg D, Dion MJ, Al-Otaibi B, Menzies D. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment. Int J Tuberc Lung Dis. 2010;14:551–9.PubMed Trajman A, Long R, Zylberberg D, Dion MJ, Al-Otaibi B, Menzies D. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment. Int J Tuberc Lung Dis. 2010;14:551–9.PubMed
Metadata
Title
Analysis of Latent Tuberculosis Infection Treatment Adherence Among Refugees and Other Patient Groups Referred to the Baltimore City Health Department TB Clinic, February 2009–March 2011
Authors
Jennifer B. Nuzzo
Jonathan E. Golub
Patrick Chaulk
Maunank Shah
Publication date
01-02-2015
Publisher
Springer US
Published in
Journal of Immigrant and Minority Health / Issue 1/2015
Print ISSN: 1557-1912
Electronic ISSN: 1557-1920
DOI
https://doi.org/10.1007/s10903-013-9882-9

Other articles of this Issue 1/2015

Journal of Immigrant and Minority Health 1/2015 Go to the issue